top of page

Revolutionary
Preclinical
Evaluation.

NFRF-T logo

Funded by a $24,000,000  grant through the federal
New Frontiers in Research Program, the TRanslational Initiative to ​DErisk NeuroTherapeutics
(TRIDENT) platform is offers a transformative approach to the preclinical evaluation of neurotherapeutics.  TRIDENT will dramatically improve the odds of success of  neurotherapeutics in clinical trials for the benefit of humans across the globe.

One Platform.
3 Integrated Model Systems.

Our Partners

CAMH logo
McGill logo
U of T logo

LEADING ACADEMIC COLLABORATION

Douglas logo
The Neuro logo
Western logo
Contact Us
bottom of page